Speaker in this video:
Dr Ramesh Matur, Sr VP and Head, Vaccines R&D Division, Biological E
Topic: Role of formulations in targeted delivery of m/RNA for vaccines, therapeutics and in vivo gene editing
Key Highlights:
[1] Lipid nanoparticles (LNPs) have emerged as a crucial non-viral platform for delivering mRNA safely and effectively, especially for vaccines, therapeutics, and gene editing applications.
[2] With a strong ecosystem in chemistry, biology, and data integration, Indian scientists have the opportunity to leap ahead in developing novel RNA-based therapeutics and IP for unmet and rare diseases
[3] With the RNA field rapidly expanding, there’s a window of opportunity to create novel IP in delivery systems, biomolecules, and therapeutic platforms.